Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP292550.RAHnb-be3BJg2v_IGdKb5dosYhnjZG8HeJQLKUAtwpy1w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP292550.RAHnb-be3BJg2v_IGdKb5dosYhnjZG8HeJQLKUAtwpy1w130_assertion type Assertion NP292550.RAHnb-be3BJg2v_IGdKb5dosYhnjZG8HeJQLKUAtwpy1w130_head.
- NP292550.RAHnb-be3BJg2v_IGdKb5dosYhnjZG8HeJQLKUAtwpy1w130_assertion wasGeneratedBy ECO_0000203 NP292550.RAHnb-be3BJg2v_IGdKb5dosYhnjZG8HeJQLKUAtwpy1w130_provenance.
- NP292550.RAHnb-be3BJg2v_IGdKb5dosYhnjZG8HeJQLKUAtwpy1w130_assertion wasDerivedFrom befree-20140225 NP292550.RAHnb-be3BJg2v_IGdKb5dosYhnjZG8HeJQLKUAtwpy1w130_provenance.
- NP292550.RAHnb-be3BJg2v_IGdKb5dosYhnjZG8HeJQLKUAtwpy1w130_assertion SIO_000772 20112253 NP292550.RAHnb-be3BJg2v_IGdKb5dosYhnjZG8HeJQLKUAtwpy1w130_provenance.
- NP292550.RAHnb-be3BJg2v_IGdKb5dosYhnjZG8HeJQLKUAtwpy1w130_assertion evidence source_evidence_literature NP292550.RAHnb-be3BJg2v_IGdKb5dosYhnjZG8HeJQLKUAtwpy1w130_provenance.
- NP292550.RAHnb-be3BJg2v_IGdKb5dosYhnjZG8HeJQLKUAtwpy1w130_assertion description "[Thus, therapeutic approaches aimed at inactivating PLK1 and/or reactivating PLK2-4 might be highly useful in the treatment of human liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP292550.RAHnb-be3BJg2v_IGdKb5dosYhnjZG8HeJQLKUAtwpy1w130_provenance.